Sign In
Buy WGS
$53.13
+1.13 (+2.17%)
At Close: Jun 02, 2026
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS
09:00am, Thursday, 28'th May 2026
SAN FRANCISCO, May 28, 2026 /PRNewswire/ -- Investors in GeneDx Holdings Corp. (NASDAQ: WGS) saw the price of their shares tank $33.42 (-49%) on May 5, 2025 after the company announced a massive Q1 2
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative – Hagens Berman
07:47pm, Wednesday, 27'th May 2026
SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) -- Investors in GeneDx Holdings Corp. (NASDAQ: WGS) saw the price of their shares tank $33. 42 (-49%) on May 5, 2025 after the company announced a massive
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative – Hagens Berman
07:47pm, Wednesday, 27'th May 2026
SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) -- Investors in GeneDx Holdings Corp. (NASDAQ: WGS) saw the price of their shares tank $33.42 (-49%) on May 5, 2025 after the company announced a massive Q
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
04:05pm, Tuesday, 26'th May 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS) today announced that management will participate in the Goldman Sachs Healthcare Conference from June 8-10 in Miami, FL.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
03:33pm, Thursday, 21'st May 2026
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised t
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?
10:23am, Thursday, 21'st May 2026
AI-driven health intelligence provider GeneDx attracted a notable insider buy, as recent filings highlight activity amid a volatile year.
Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud
09:30am, Wednesday, 20'th May 2026
PHILADELPHIA, May 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that it is investigating GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of shareholders who have lost mo
GeneDx Holdings Corp. (WGS) Securities Fraud Investigation - Levi & Korsinsky
09:00am, Wednesday, 20'th May 2026
GeneDx posted Q1 2026 revenue of $102.3 million against consensus estimates near $110 million and reported adjusted EPS of -$0.28 versus the -$0.01 expected -- the stock collapsed approximately 44% in
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GeneDx (WGS) To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
05:21pm, Tuesday, 19'th May 2026
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS). Such investors are a
WGS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
07:00pm, Monday, 18'th May 2026
NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ:WG
Fraud Investigation Opened: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) on Behalf of Shareholders
12:41am, Monday, 18'th May 2026
New York, New York--(Newsfile Corp. - May 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into GeneDx Holdings Corp. (NASDAQ: WGS) ("GeneDx Holdings Corp.") con
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
08:02pm, Thursday, 14'th May 2026
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised t
Levi & Korsinsky Announces Investigation of Securities Claims Against GeneDx Holdings Corp. (WGS)
09:00am, Thursday, 14'th May 2026
GeneDx stock collapsed approximately 44% after Q1 2026 earnings revealed a major revenue miss and a roughly 12% cut to full-year guidance -- weeks after management publicly reaffirmed its outlook Gene
GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity
07:31am, Thursday, 14'th May 2026
GeneDx Holdings Corp. specializes in advanced exome and genome diagnostic testing, leveraging its proprietary GeneDx Infinity dataset for superior interpretation. Q1 2026 results missed expectations,
